E. Claire Newbern, PhD, MPH

Director, Global Epidemiology
Johnson and Johnson Innovative Medicine, United States

Claire joined the Janssen Global Epidemiology Organization in December 2021 to support infectious disease products and vaccines. She has coordinated the IDV Epidemiology team activities supporting the Janssen COVID-19 vaccine. Her previous work has primarly been in the public sector - notifiabile disease surveillance, immunizations, and studies on respiratory viruses.

Disclosure information not submitted.

Presentation(s):

• Ad26.COV2.S vaccine and thromboembolic risks among premenopausal women: Exploring variation by combined hormonal medication use

  Monday, August 26, 2024
  5:30 PM – 5:45 PM CEST